Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-21-022860

Chief Medical Officer sold 3,750 shares at $25.97 ($97,394)

From the SEC's structured data for this filing

Trades in this filing

Melian Agustin · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-03-22 Sale : show line 1 in the form −3,750 $25.97 $97,394 516,516 D
Open-market sales · 3,750 sh · avg $25.97 · $97,394
Loading xslF345X03/doc4.xml…